Oct 27, 2016 12:30 pm UTC| Business
WALTHAM, Mass., Oct. 27, 2016 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...
Buckeye Partners, L.P. Announces Offering of Senior Notes
Oct 27, 2016 12:19 pm UTC| Business
HOUSTON, Oct. 27, 2016 -- Buckeye Partners, L.P. (“Buckeye”) (NYSE:BPL) announced today that it plans to issue senior unsecured notes pursuant to an effective shelf registration statement on Form S-3 previously filed...
Altisource Announces Third Quarter Results
Oct 27, 2016 12:18 pm UTC| Business
LUXEMBOURG, Oct. 27, 2016 -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ:ASPS) today reported financial results for the third quarter of 2016, reporting strong cash flows from operations...
Oct 27, 2016 12:08 pm UTC| Business
EMERYVILLE, Calif., Oct. 27, 2016 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ADS-5102 (amantadine...
Monster Beverage to Report 2016 Third Quarter Financial Results November 3, 2016
Oct 27, 2016 12:08 pm UTC| Business
CORONA, Calif., Oct. 27, 2016 -- Monster Beverage Corporation (NASDAQ:MNST) today announced that results for its third quarter ended September 30, 2016 will be released Thursday, November 3, 2016, after the close of the...
Monster Beverage to Report 2016 Third Quarter Financial Results November 3, 2016
Oct 27, 2016 12:08 pm UTC| Business
CORONA, Calif., Oct. 27, 2016 -- Monster Beverage Corporation (NASDAQ:MNST) today announced that results for its third quarter ended September 30, 2016 will be released Thursday, November 3, 2016, after the close of the...
Independent Bank Corporation Reports 2016 Third Quarter Results
Oct 27, 2016 12:07 pm UTC| Business
GRAND RAPIDS, Mich., Oct. 27, 2016 -- Independent Bank Corporation (NASDAQ:IBCP) reported third quarter 2016 net income of $6.4 million, or $0.30 per diluted share, versus net income of $5.0 million, or $0.22 per...